Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorChichagova, Valeria-
dc.descriptionPhD Thesisen_US
dc.description.abstractThe heteroplasmic mutation in the mitochondrial gene MT-TL1 encoding tRNALeucine (UUR) at nucleotide position 3243 resulting in the arginine to guanine transition (m.3243A>G) is the most common pathogenic mutation in the mitochondrial genome. Originally associated with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes syndrome, it has also been linked to a number of other clinical phenotypes. It is common for patients harbouring the mutation to develop a range of ocular abnormalities, including those affecting retinal pigment epithelium (RPE) cells. The underlying mechanisms of RPE degeneration remain unclear. Using fibroblasts derived from patients with retinal changes with the m.3243A>G, I generated heteroplasmic human induced pluripotent stem cell (hiPSC) clones harbouring the m.3243A>G mutation. RPE cells differentiated from patient hiPSCs displayed typical cobblestone morphology and expressed mature RPE-associated markers. The RPE cells retained their ability to form blood-retinal barrier as assessed by measuring transepithelial resistance. However, cells with high levels of the m.3243A>G showed reduced propensity for pigment formation. Additionally, the RPE cells contained abnormal mitochondria and melanosomes, which is likely to manifest as a reduced ability to absorb stray light. These findings have remarkable similarities to the ones seen in RPE cells described in post mortem tissues of patients with the m.3243A>G mutation. In addition, patient cells showed defects in phagocytosis of photoreceptor outer segments, a functional defect associated with other retinal diseases. Overall, the results provide an indication that RPE cells with the m.3243A>G have reduced ability to perform at least two of their main functions: absorption of stray light and phagocytosis, suggesting possible pathological processes associated with ocular symptoms seen in patients. The ability to mimic these manifestations in vitro would allow investigating pathological mechanisms further and allow testing novel therapeutic agents aimed at alleviating or treating the symptoms.en_US
dc.description.sponsorshipDr William Edmund Harker Foundation, ERC (#614620) and Northern Academic Health Sciences Network for funding this project.en_US
dc.publisherNewcastle Universityen_US
dc.titleInvestigating retinal pathology in patients carrying m.3243A>G mutation using human induced pluripotent stem cellsen_US
Appears in Collections:Institute of Genetic Medicine

Files in This Item:
File Description SizeFormat 
Chichagova, V. 2017.pdfThesis6.79 MBAdobe PDFView/Open
dspacelicence.pdfLicence43.82 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.